Apex Evergreen
PHARMACEUTICALS
Where Science Meets Sovereignty
Facilities
Served
Reached
Quality Without Compromise. Access Without Borders.
We believe that geography should never determine the quality of medicine a person receives. From the laboratories of India to the pharmacies of five continents, Apex Evergreen exists to close that gap — with precision, integrity, and an unrelenting commitment to life.
"Every molecule we deliver carries the weight of a promise — not to markets, but to the human beings waiting on the other side of that supply chain."
When I founded Apex Evergreen, I wasn't building a company. I was building an answer to a question that had haunted me for years: why should geography determine the quality of healthcare you receive?
India has always had the pharmaceutical excellence the world needs. What it required was a bridge — a meticulous, accountable hand that could take the finest of what we manufacture and place it, reliably and with unwavering integrity, into the hands of those who need it most.
Today, we stand across five continents — not as intermediaries, but as custodians of quality. Every product that bears our name has earned that privilege. Every partnership in our ecosystem exists because we asked the hardest question first: is this good enough for my own family?
The answer has always had to be yes. It always will be.
Dharohar Sahadot
One Standard.
Every Continent.
From our export house in Pune, Apex Evergreen operates regional offices across five continents — each an extension of our founding promise.
B-936, Imperium Gateway
LATAM Distribution Hub
Commercial Office
Distribution Centre
Regulatory Affairs
Every Dosage Form.
Every Standard.
A comprehensive portfolio spanning 12 therapeutic categories and every major dosage form — designed for both regulated and emerging markets.
Vaccines & Biologicals
PCV-13, Sheep Pox (RM-65), hormonal injectables, and WHO-certified biological products for human and veterinary use.
Ophthalmic Preparations
Premium eye drops and ophthalmic solutions — our flagship line for Latin America. Manufactured to the highest sterility and efficacy standards.
Nasal Sprays
Advanced intranasal drug delivery systems with precision metered-dose technology for systemic and local therapeutic applications.
Tablets & Capsules
Immediate-release, sustained-release, and enteric-coated solid oral dosage forms manufactured across multiple high-throughput facilities.
Injectables
Hormonal injectables, veterinary biologicals, and sterile preparations manufactured in dedicated aseptic suites with full cold chain capability.
Oral Liquids
Syrups, suspensions, and solutions formulated for precise bioavailability, paediatric applications, and tropical climate stability.
Topical Formulations
Creams, ointments, gels, and lotions — developed for dermatological, anti-fungal, and musculoskeletal therapeutic applications worldwide.
Sachets & Nutraceuticals
Effervescent granules, nutrition supplements, and therapeutic sachets. Our nutraceutical line bridges pharmaceutical quality with wellness applications.
Not Just a Supplier.
A Pioneer.
PCV-13 Pneumococcal Conjugate Vaccine
We are only the second company in the world — after Pfizer — to achieve access to the PCV-13 vaccine at scale. Protecting against 13 serotypes of Streptococcus pneumoniae, PCV-13 guards against pneumonia, meningitis, and septicaemia — diseases that claim over 1.6 million lives annually. For markets in Latin America, Sub-Saharan Africa, and Southeast Asia, our access to WHO-certified PCV-13 is not a business achievement. It is a lifesaving imperative.
Ophthalmic Expertise
Our ophthalmic line — spanning sterile eye drops, anti-glaucoma preparations, and preservative-free formulations — is our flagship offering for the LATAM market, where demand for affordable, regulated eye care is growing rapidly.
Veterinary Biologicals
Among the first companies globally to introduce the Sheep Pox Vaccine with the RM-65 strain — specifically engineered for European-breed sheep and goats. A breakthrough in transboundary livestock disease control.
Clinical Research Access
Through our strategic CRO partnership with Ibhaan Pharmaceuticals, we facilitate Phase I–III clinical trials and bioequivalence studies — enabling market authorizations in regulated territories including the EU and USA.
21 Facilities.
One Standard.
Our manufacturing ecosystem is not a vendor list — it is a curated network of India's most distinguished pharmaceutical manufacturers, each selected for their regulatory pedigree, production capacity, and alignment with our uncompromising quality ethos.
Facilities
The Gold Standard
Is Our Standard.
Every product supplied through Apex Evergreen meets — and typically exceeds — the requirements of the world's most demanding regulatory authorities.
World Health Organization GMP
The global baseline for pharmaceutical manufacturing quality. All ecosystem partners operate under WHO Good Manufacturing Practice guidelines, ensuring product safety, efficacy, and consistency.
US Food & Drug Administration
Multiple partners in our network hold active USFDA clearances, enabling compliant supply to the United States — one of the world's most stringent pharmaceutical regulatory jurisdictions.
European GMP Certification
EU-GMP certified facilities provide the gateway to European markets, ensuring our products meet the rigorous EMA quality requirements required for pharmaceutical import across EU member states.
Pharmaceutical Inspection Convention
PIC/S membership — the most comprehensive pharmaceutical inspection network globally — is held by several of our key manufacturing partners, validating their quality systems across 55 participating authorities.
"We don't meet the minimum standard. We set the standard we're willing to be held to."
From Discovery
to Market.
Through our strategic CRO partnership with Ibhaan Pharmaceuticals, Apex Evergreen clients gain access to full-spectrum clinical research services — from early-phase human pharmacokinetic studies through Phase III trials required for regulatory submissions in the EU, USA, and emerging markets.
Whether you're pursuing a first-in-class molecule or seeking bioequivalence data for a generic application, our research partnership fast-tracks your path from laboratory confidence to market approval.
Ibhaan Pharmaceuticals
Questions &
Answers.
Unlike traditional intermediaries, Apex Evergreen operates as a fully integrated pharmaceutical ecosystem. We've curated an interconnected network of 21 manufacturing facilities — each selected for their regulatory standing, production capabilities, and product excellence. Our difference is accountability: we stand behind every product as if it left our own facility. Every client is treated as our only client.
We operate through a carefully constructed ecosystem of strategic manufacturing partnerships with India's most distinguished pharmaceutical manufacturers. Each facility is vetted against the same non-negotiable standards we hold ourselves to. The distinction between ownership and stewardship matters less than the quality guarantee that accompanies every product we supply — a guarantee that is entirely ours to honour.
Every product in our portfolio is manufactured under internationally recognised standards. Our ecosystem encompasses facilities certified under WHO-GMP, EU-GMP, USFDA, and PIC/S — with most facilities holding multiple certifications. This ensures your products meet the requirements of both regulated markets (US, EU) and rapidly growing semi-regulated markets worldwide.
The Pneumococcal Conjugate Vaccine PCV-13 protects against 13 serotypes of Streptococcus pneumoniae — one of the leading causes of pneumonia, meningitis, and septicaemia worldwide. Pfizer was the first company to market this vaccine globally. Apex Evergreen is only the second company in the world with access to WHO-certified PCV-13 at scale. For markets in Latin America, Africa, and Asia, this represents life-changing access to world-class immunisation at an accessible price point.
Yes. Select manufacturing partners in our ecosystem hold active USFDA clearances and EU-GMP certifications, enabling supply to the most demanding regulatory environments globally. We provide complete regulatory documentation support — Certificate of Analysis, Certificate of Pharmaceutical Product, stability data, and dossier preparation — for seamless market entry.
Yes. Our veterinary portfolio includes high-demand biologicals such as the Sheep Pox Vaccine with the RM-65 strain — specifically formulated for European sheep and goat breeds. We were among the first companies globally to offer this advanced formulation at export scale. Our veterinary range covers a broad spectrum of livestock health products for emerging and regulated markets.
Through our strategic CRO partnership with Ibhaan Pharmaceuticals, we facilitate Phase I–III clinical trials, bioequivalence studies, and pharmacokinetic research. This is particularly valuable for clients seeking market authorisations in the EU and North America, where clinical data is a regulatory prerequisite.
All partnerships begin with a conversation. Reach our team at our Pune headquarters, or through our regional offices in New York, Dubai, São Paulo, Santiago, or Bucharest. We schedule a discovery call to understand your market, therapeutic focus, and regulatory requirements — then propose a tailored supply solution. Contact us at +91 73505 73588 or visit our offices at B-936, Imperium Gateway, Pune, India.